ResMed, the leading global manufacturer of CPAP machines and masks used in the treatment of sleep apnea, has recently completed the acquisition of Somnoware, a prominent U.S. company specialising in diagnostic software for sleep and respiratory care. The financial terms of the acquisition have not been disclosed.
Somnoware's advanced software offers a range of benefits for physicians and sleep labs involved in diagnosing and evaluating patients' sleep and respiratory care test results. The software simplifies various processes, including ordering treatment equipment, scheduling appointments, monitoring therapy compliance, and seamlessly integrating this information into patients' electronic health records.
Importantly, the Somnoware platform will maintain its openness, allowing sleep labs, pulmonary function testing facilities, and physicians to access and review results from a variety of testing solutions.
By combining the strengths of ResMed and Somnoware, the acquisition seeks to drive innovation and improve patient outcomes in the sleep and respiratory care industry. The integration of these two industry leaders will pave the way for enhanced efficiency and comprehensive care for individuals suffering from sleep-related disorders.
Click here to read the original news story.